Oncology & Cancer

Looking at tumors through a new lens

Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types, and has recently been shown to provide a modest survival benefit for patients with recurrent glioblastoma. To improve ...

Immunology

Team discovers how cells distinguish friend from foe

(Medical Xpress)—Researchers at UC Davis have shown how the innate immune system distinguishes between dangerous pathogens and friendly microbes. Like burglars entering a house, hostile bacteria give themselves away by ...

Oncology & Cancer

3-D-printed tumor model shows interaction with immune cells

Around a glioblastoma, a very aggressive brain tumor, cells of the human immune system help the tumor instead of attacking it. To explore the interaction of these cells, scientists of the University of Twente have created ...

Oncology & Cancer

Immune system changes may drive aggressiveness of recurrent tumors

Nearly half of the 700,000 cancer patients who undergo surgical removal of a primary tumor each year suffer a recurrence of their disease at some point, and many of those patients will eventually die from their disease. The ...

Diseases, Conditions, Syndromes

C. difficile lengthens hospital stays by 6 days

A new study published in the CMAJ (Canadian Medical Association Journal) reports that hospital-acquired Clostridium difficile infection increases length of stay in hospital by an average of six days.

page 35 from 40